查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1316488

細胞活力檢測市場：按產品類型（消耗品、設備）、細胞類型（動物細胞、人類細胞、微生物細胞）、用途和最終用戶 - 2023-2030 年全球預測

Cell Viability Assays Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells, Microbial Cells), Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球細胞活力檢測市場預計到2023年將大幅成長，達到17.9717億美元，年複合成長率為11.31%，到2030年將達到38.2195億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球細胞活力檢測市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 細胞活力檢測的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球細胞活力檢測市場的阻礙因素和影響為何？

3.在預測期內，全球細胞活力檢測市場需要投資哪些產品/細分市場/用途/領域？

4. 全球細胞活力檢測市場的競爭策略為何？

5.全球細胞活力檢測市場的技術趨勢和法律規範是什麼？

6.全球細胞活力檢測市場主要供應商的市佔率為何？

7. 哪些型態和策略措施被認為適合進入全球細胞活力檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 增加細胞研究的投資
      • 各國臨床試驗數量增加
      • 利用細胞活力測定法來篩選水體
    • 抑制因素
      • 試劑和細胞活力測定的成本高昂
    • 機會
      • 開發用於細胞活力測定的高靈敏度和快速方案
      • 在品管操作中採用細胞活力
    • 任務
      • 細胞活力測定的技術限制
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 細胞活力測定市場：依產品

  • 介紹
  • 消耗品
  • 裝置

第7章 細胞活力測定市場：依細胞類型

  • 介紹
  • 動物細胞
  • 人體細胞
  • 微生物細胞

第8章 細胞活力測定市場：依用途

  • 介紹
  • 基礎研究
  • 臨床和診斷用途
  • 藥物研發發現與開發
  • 幹細胞研究

第9章 細胞活力測定市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第10章 美洲細胞活力檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞活力檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲細胞活力檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-957C47F94DEA

The Global Cell Viability Assays Market is forecasted to grow significantly, with a projected USD 1,797.17 million in 2023 at a CAGR of 11.31% and expected to reach a staggering USD 3,821.95 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell Viability Assays Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell Viability Assays Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Instruments. The Consumables is projected to witness significant market share during forecast period.

Based on Cell Type, market is studied across Animal Cells, Human Cells, and Microbial Cells. The Animal Cells is projected to witness significant market share during forecast period.

Based on Application, market is studied across Basic Research, Clinical & Diagnostic Applications, Drug Discovery & Development, and Stem Cell Research. The Drug Discovery & Development is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell Viability Assays Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell Viability Assays Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Viability Assays Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Viability Assays Market?

4. What is the competitive strategic window for opportunities in the Global Cell Viability Assays Market?

5. What are the technology trends and regulatory frameworks in the Global Cell Viability Assays Market?

6. What is the market share of the leading vendors in the Global Cell Viability Assays Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell Viability Assays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Viability Assays Market, by Product, 2022 vs 2030
  • 4.3. Cell Viability Assays Market, by Cell Type, 2022 vs 2030
  • 4.4. Cell Viability Assays Market, by Application, 2022 vs 2030
  • 4.5. Cell Viability Assays Market, by End-User, 2022 vs 2030
  • 4.6. Cell Viability Assays Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in cell-based research
      • 5.1.1.2. Rising number of clinical trials in economies
      • 5.1.1.3. Utilization of cell viability assays to screen water bodies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of reagents and cell viability assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of highly sensitive and rapid protocol cell viability assays
      • 5.1.3.2. Adoption of cell viability in quality control operations
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of cell viability assay
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cell Viability Assays Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Cell Viability Assays Market, by Cell Type

  • 7.1. Introduction
  • 7.2. Animal Cells
  • 7.3. Human Cells
  • 7.4. Microbial Cells

8. Cell Viability Assays Market, by Application

  • 8.1. Introduction
  • 8.2. Basic Research
  • 8.3. Clinical & Diagnostic Applications
  • 8.4. Drug Discovery & Development
  • 8.5. Stem Cell Research

9. Cell Viability Assays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospital & Diagnostic Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Cell Viability Assays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Viability Assays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Viability Assays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CELL VIABILITY ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL VIABILITY ASSAYS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2022 VS 2030 (%)
  • FIGURE 6. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. CELL VIABILITY ASSAYS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CELL VIABILITY ASSAYS MARKET DYNAMICS
  • FIGURE 10. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL VIABILITY ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL VIABILITY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CELL VIABILITY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CELL VIABILITY ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. CELL VIABILITY ASSAYS MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL VIABILITY ASSAYS MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL VIABILITY ASSAYS MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL VIABILITY ASSAYS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL VIABILITY ASSAYS MARKET SIZE, BY CLINICAL & DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL VIABILITY ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL VIABILITY ASSAYS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. CELL VIABILITY ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL VIABILITY ASSAYS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL VIABILITY ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CELL VIABILITY ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. CELL VIABILITY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 189. CELL VIABILITY ASSAYS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 190. CELL VIABILITY ASSAYS MARKET LICENSE & PRICING